Runzhi Xia1,2, Wei Sun1, Jiaming Liang2,3

  • 1China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100029, P. R. China.

概括

一种新的融合 (ER) 增强了瘤选择性癌细胞杀死和药物输送. 这种可注射的水凝平台在临床前模型中显示出高效率和无毒性,提供了有前途的骨髓瘤治疗方法.